NM_001378789.1:c.999+173T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378789.1(CERS3):​c.999+173T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.492 in 151,940 control chromosomes in the GnomAD database, including 18,763 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 18763 hom., cov: 32)

Consequence

CERS3
NM_001378789.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.37

Publications

3 publications found
Variant links:
Genes affected
CERS3 (HGNC:23752): (ceramide synthase 3) This gene is a member of the ceramide synthase family of genes. The ceramide synthase enzymes regulate sphingolipid synthesis by catalyzing the formation of ceramides from sphingoid base and acyl-coA substrates. This family member is involved in the synthesis of ceramides with ultra-long-chain acyl moieties (ULC-Cers), important to the epidermis in its role in creating a protective barrier from the environment. The protein encoded by this gene has also been implicated in modification of the lipid structures required for spermatogenesis. Mutations in this gene have been associated with male fertility defects, and epidermal defects, including ichthyosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
CERS3 Gene-Disease associations (from GenCC):
  • autosomal recessive congenital ichthyosis 9
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • congenital non-bullous ichthyosiform erythroderma
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 15-100455720-A-G is Benign according to our data. Variant chr15-100455720-A-G is described in ClinVar as Benign. ClinVar VariationId is 1221617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.54 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378789.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CERS3
NM_001378789.1
MANE Select
c.999+173T>C
intron
N/ANP_001365718.1Q8IU89
CERS3
NM_001290341.2
c.1032+173T>C
intron
N/ANP_001277270.1Q8IU89
CERS3
NM_001290342.2
c.999+173T>C
intron
N/ANP_001277271.1Q8IU89

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CERS3
ENST00000679737.1
MANE Select
c.999+173T>C
intron
N/AENSP00000506641.1Q8IU89
CERS3
ENST00000284382.8
TSL:1
c.999+173T>C
intron
N/AENSP00000284382.4Q8IU89
CERS3
ENST00000394113.5
TSL:1
c.999+173T>C
intron
N/AENSP00000377672.3Q8IU89

Frequencies

GnomAD3 genomes
AF:
0.493
AC:
74791
AN:
151822
Hom.:
18773
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.427
Gnomad AMI
AF:
0.549
Gnomad AMR
AF:
0.454
Gnomad ASJ
AF:
0.517
Gnomad EAS
AF:
0.399
Gnomad SAS
AF:
0.429
Gnomad FIN
AF:
0.523
Gnomad MID
AF:
0.547
Gnomad NFE
AF:
0.545
Gnomad OTH
AF:
0.533
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.492
AC:
74791
AN:
151940
Hom.:
18763
Cov.:
32
AF XY:
0.489
AC XY:
36335
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.427
AC:
17688
AN:
41446
American (AMR)
AF:
0.453
AC:
6922
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.517
AC:
1794
AN:
3470
East Asian (EAS)
AF:
0.399
AC:
2065
AN:
5174
South Asian (SAS)
AF:
0.427
AC:
2057
AN:
4812
European-Finnish (FIN)
AF:
0.523
AC:
5503
AN:
10526
Middle Eastern (MID)
AF:
0.541
AC:
159
AN:
294
European-Non Finnish (NFE)
AF:
0.545
AC:
36991
AN:
67932
Other (OTH)
AF:
0.527
AC:
1112
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1927
3853
5780
7706
9633
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.496
Hom.:
3073
Bravo
AF:
0.487
Asia WGS
AF:
0.408
AC:
1414
AN:
3470

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
14
DANN
Benign
0.91
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12050655; hg19: chr15-100995925; COSMIC: COSV52573362; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.